An overview of clinical trials

Journal of Vascular Nursing

Volumn 22, Issue 1, 2004, Pages 32-34

  Rich, Kathleen ^a,b,c  

^a Methodist Hospital Gary   (United States)

^b Methodist Hospitals Inc   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GEMCITABINE; PLACEBO; THALIDOMIDE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL MODEL; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ENDARTERECTOMY; FOOD AND DRUG ADMINISTRATION; HUMAN; KIDNEY CARCINOMA; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZATION; REVASCULARIZATION; SHORT SURVEY; SIDE EFFECT; STENT; THROMBOEMBOLISM;

EID: 1442286479     PISSN: 10620303     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1062-0303(03)00116-X     Document Type: Article

References (13)

1. Food and Drug Administration: the new drug approval process. Available at: http://www/fda.gov/cder/handbook.
2. National Institutes of Health: introduction to clinical trials. Available at: http://www.clinicaltrials.gov.
3. Polit D., Beck C., Hungler B. Essentials of nursing research. 5th edition:2001;166-175 W.B. Saunders, Philadelphia.
4. Burns N., Grove S. Understanding nursing research. 3rd edition:2003;214-218 W.B. Saunders, Philadelphia.
5. Allen M. Randomized clinical trials attention to bias. J Wound Ostomy Continence Nurs. 29:2002;127-128.
6. Liang B. The drug development process II investigational new drug application. Hosp Physician. 38:2002;36-38.
7. Sims J., Miracle V. Phases of a clinical trial. Dimens Crit Care Nurs. 21:2002;152-153.
8. Liang B. The drug development process I drug discovery and initial development. Hosp Physician. 38:2002;1-21.
9. Brener B., Faries P., Connelly T., et al. An in situ adjustable endovascular graft for the treatment of abdominal aortic aneurysms. J Vasc Surg. 35:2002;114-119.
10. Desai A., Vogelzang N., Rini B., et al. A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma. Cancer. 95:2002;1629-1636.
11. Roubin G., Hobson R., White R., et al. CREST and Caress to evaluate carotid stenting time to get to work! J Endovasc Ther. 8:2001;107-110.
12. Liang B. The drug development process III phase IV clinical trials. Hosp Physician. 38:2002;42-44.
13. Chiu D., Krieger D., Villar-Cordova C., et al. Intravenous tissue plasminogen activator for acute ischemic stroke feasibility, safety and efficacy in the first year of clinical practice. Stroke. 29:1998;18-22.